Literature DB >> 11119474

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement.

I Müller, M Seyfarth, S Rüdiger, B Wolf, G Pogatsa-Murray, A Schömig, M Gawaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11119474      PMCID： PMC1729582          DOI： 10.1136/heart.85.1.92

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  16 in total

Review 1.  Radiofrequency catheter ablation of ventricular tachycardia.

Authors:  W G Stevenson; E Delacretaz
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

Review 2.  Heart disease in the elderly.

Authors:  M Lye; C Donnellan
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

3.  When should ACE inhibitors or warfarin be discontinued after myocardial infarction?

Authors:  S E Wiegers; M St John Sutton
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

4.  Pharmacogenetics and the treatment of cardiovascular disease.

Authors:  M R Wilkins; A D Roses; C P Clifford
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

5.  A comparison of four quality of life instruments in cardiac patients: SF-36, QLI, QLMI, and SEIQoL.

Authors:  H J Smith; R Taylor; A Mitchell
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

Review 6.  Thyroid disease and the heart.

Authors:  A D Toft; N A Boon
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

7.  Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS).

Authors:  M E Bertrand; H J Rupprecht; P Urban; A H Gershlick
Journal:  Circulation       Date:  2000-08-08       Impact factor: 29.690

8.  Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.

Authors:  M Gawaz; A Ruf; F J Neumann; G Pogátsa-Murray; T Dickfeld; D Zohlnhöfer; A Schömig
Journal:  Thromb Haemost       Date:  1998-12       Impact factor: 5.249

9.  Clopidogrel as adjunctive antiplatelet therapy during coronary stenting.

Authors:  G J Mishkel; F V Aguirre; R W Ligon; K J Rocha-Singh; C L Lucore
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

10.  Knowledge and communication difficulties for patients with chronic heart failure: qualitative study.

Authors:  A E Rogers; J M Addington-Hall; A J Abery; A S McCoy; C Bulpitt; A J Coats; J S Gibbs
Journal:  BMJ       Date:  2000-09-09
View more
  44 in total

1.  Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention.

Authors:  Patrik Htun; Suzanne Fateh-Moghadam; Christian Bischofs; Winston Banya; Karin Müller; Boris Bigalke; Konstantinos Stellos; Andreas E May; Marcus Flather; Meinrad Gawaz; Tobias Geisler
Journal:  J Am Soc Nephrol       Date:  2011-01-27       Impact factor: 10.121

2.  Effect of chronic kidney disease on platelet reactivity to dual-antiplatelet therapy in patients treated with drug-eluting stents.

Authors:  Takahide Arai; Akio Kawamura; Yumiko Matsubara; Kenji Yokoyama; Yasuo Ikeda; Keiichi Fukuda; Mitsuru Murata
Journal:  Heart Vessels       Date:  2011-08-12       Impact factor: 2.037

Review 3.  Changing roles of anticoagulant and antiplatelet treatment during percutaneous coronary intervention.

Authors:  R V Kelly; S Steinhubl
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

4.  Understanding clopidogrel efficacy in the presence of cytochrome P450 polymorphism.

Authors:  Jacques Turgeon; Chantal Pharand; Véronique Michaud
Journal:  CMAJ       Date:  2006-06-06       Impact factor: 8.262

Review 5.  Antiplatelet treatment for coronary heart disease.

Authors:  N Clappers; M A Brouwer; F W A Verheugt
Journal:  Heart       Date:  2007-02       Impact factor: 5.994

6.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 7.  Contemporary use of clopidogrel in patients with coronary artery disease.

Authors:  Sahil A Parikh; Joshua A Beckman
Journal:  Curr Cardiol Rep       Date:  2007-07       Impact factor: 2.931

Review 8.  Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements.

Authors:  Joseph M Sweeny; Diana A Gorog; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

Review 9.  Contemporary issues on clopidogrel therapy.

Authors:  Giuseppe Patti; Germano Di Sciascio
Journal:  Intern Emerg Med       Date:  2009-01-08       Impact factor: 3.397

Review 10.  Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond.

Authors:  S J Walsh; M S Spence; D Crossman; A A J Adgey
Journal:  Heart       Date:  2005-09       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.